BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4595317)

  • 1. BCG immunotherapy in Burkitt's lymphoma: preliminary results of a randomized clinical trial.
    Ziegler JL; Magrath IT
    Natl Cancer Inst Monogr; 1973 Dec; 39():199-202. PubMed ID: 4595317
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous remission in Burkitt's lymphoma.
    Ziegler JL
    Natl Cancer Inst Monogr; 1976 Nov; 44():61-5. PubMed ID: 799761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.
    Magrath IT; Ziegler JL
    Br Med J; 1976 Mar; 1(6010):615-8. PubMed ID: 766905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous reactivity to the so-called "recall" antigens in 4 patients with Burkitt's African lymphoma].
    Jirillo E; Frugis Caggianelli L; De Rinaldis P; Fumarola D
    Pathologica; 1976; 68(979-980):247-52. PubMed ID: 1018982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Burkitt's hematosarcoma in North Africa].
    Gouiric R; Bouchouchi M; Hafiz S
    Rev Stomatol Chir Maxillofac; 1976; 77(1):63-5. PubMed ID: 1064110
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression in Burkitt's lymphoma. I. Cutaneous reactivity to recall antigens: alterations induced by a tumour burden and by BCG administration.
    Magrath IT
    Int J Cancer; 1974 Jun; 13(6):839-49. PubMed ID: 4604572
    [No Abstract]   [Full Text] [Related]  

  • 7. Current concepts. Recent research in Burkitt's lymphoma.
    Ziegler JL; Kyalwazi SK
    East Afr Med J; 1971 Nov; 48(11):670-5. PubMed ID: 4947499
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of chronic myelocytic leukemia.
    Sokal JE; Aungst CW; Grace JT
    Natl Cancer Inst Monogr; 1973 Dec; 39():195-8. PubMed ID: 4595316
    [No Abstract]   [Full Text] [Related]  

  • 9. An experimental model for immunotherapy of cancer.
    Zbar B; Ribi E; Rapp HJ
    Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
    Gunvén P
    Hamatol Bluttransfus; 1974; 14():129-32. PubMed ID: 4375070
    [No Abstract]   [Full Text] [Related]  

  • 11. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of malignant melanoma by intratumoral injection of BCG.
    Pinsky CM; Hirshaut Y; Oettgen HF
    Natl Cancer Inst Monogr; 1973 Dec; 39():225-8. PubMed ID: 4595322
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy of acute myelogenous leukemia in man.
    Powles R
    Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
    [No Abstract]   [Full Text] [Related]  

  • 14. The neurological picture of Burkitt's lymphoma in Ibadan.
    Odeku EL; Adeloye A; Osuntokun BO
    Afr J Med Sci; 1973 Apr; 4(2):119-26. PubMed ID: 4708620
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunity against DNA virus linked antigens in a human tumor (Burkitt's lymphoma)].
    Gunvén P
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):52-6. PubMed ID: 4145637
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined modality treatment of American Burkitt's lymphoma.
    Ziegler JL; DeVita VT; Graw RG; Herzig G; Leventhal BG; Levine AS; Pomeroy TC
    Cancer; 1976 Dec; 38(6):2225-31. PubMed ID: 1036716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of melanoma with intralesional BCG.
    Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
    Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.
    Nathanson L; Clark DA
    Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321
    [No Abstract]   [Full Text] [Related]  

  • 19. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation.
    Yamamoto K; Kato K; Kakinuma M; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of Burkitt's lymphoma in Ghana.
    Nkrumah FK; Perkins IV
    Afr J Med Sci; 1973 Apr; 4(2):209-14. PubMed ID: 4708624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.